enGene Therapeutics Files Initial Beneficial Ownership Statement for Chief Legal and Admin Officer Jason Duncan

PUBT · 1d ago
enGene Therapeutics Files Initial Beneficial Ownership Statement for Chief Legal and Admin Officer Jason Duncan
  • enGene Therapeutics Chief Legal and Administrative Officer Jason Duncan filed an initial statement of beneficial ownership dated Nov. 13, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enGene Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001552781-26-000552), on November 13, 2026, and is solely responsible for the information contained therein.